Blood News and Research

RSS

Potential block buster on the horizon - new vaccine to control high blood pressure

A vaccine that would help people control their blood pressure is showing promise in early trials.

7 Nov 2007

Dengue fever vaccine looks very promising

The vaccine Tetravalent is manufactured by drug company Sanofi who say it will be ready to be submitted for approval by the year 2012.

7 Nov 2007

Plants provide better understanding of the epidemiology and evolution of infectious disease

Animals, like plants, can build tolerance to infections at a genetic level, and these findings could provide a better understanding of the epidemiology and evolution of infectious disease, according to evolutionary biologists.

6 Nov 2007

Risk of disability increasing in older obese population in the U.S.

The older obese population in the U.S. appear to be experiencing more impairments in functional abilities related to movement, although there have been improvements in the cardiovascular health of this population, according to a study in the November 7 issue of JAMA.

6 Nov 2007

Researchers neutralise the HIV virus

With the latest advances in treatment, doctors have discovered that they can successfully neutralise the HIV virus.

6 Nov 2007

Diet type linked to cognitive decline and dementia

Research has shown convincing evidence that dietary patterns practiced during adulthood are important contributors to age-related cognitive decline and dementia risk.

6 Nov 2007

Skipping meals to lose weight

Foregoing food for a day each month stood out among other religious practices in members of the Church of Jesus Christ of Latter-Day Saints (LDS or Mormons), who have lower rates of heart disease than other Americans, researchers reported at the American Heart Association's Scientific Sessions 2007.

6 Nov 2007

New study looks at effects of obesity on disability over time

Researchers at the University of Pennsylvania School of Medicine report that older adults today are much more likely to suffer from disability than those 10 years ago.

6 Nov 2007

New liver model for drug tests

In the early stages of drug development, a drug’s effect is tested in animal experiments.

6 Nov 2007

Tezosentan does not appear to improve symptoms for patients with acute heart failure

The medication tezosentan, which was thought could be beneficial for the treatment of acute heart failure, did not improve breathlessness or reduce the risk of fatal or nonfatal cardiovascular events, according to a study in the November 7 issue of JAMA.

6 Nov 2007

Brain appears to play important role in glucose metabolism and insulin action

An appetite-suppressing chemical also improves glucose tolerance and lowers insulin levels in obese and diabetic mice, researchers report in the November issue of Cell Metabolism, a publication of Cell Press.

6 Nov 2007

Lungs' pressure needn't threaten heart transplant survival

Heart surgeons at Johns Hopkins say people who need heart transplants can largely avoid transplant failure due to elevated blood pressure in their lungs with the help of proper drug treatment.

6 Nov 2007

Inflammation causes insulin resistance not obesity

Researchers at the University of California, San Diego (UCSD) School of Medicine have discovered that inflammation provoked by immune cells called macrophages leads to insulin resistance and Type 2 diabetes.

6 Nov 2007

Hepatitis C treatment reduces the virus but serious liver problems may progress

Patients with chronic hepatitis C and advanced liver disease who did not respond to previous standard therapy experienced significant decreases in their liver enzymes, viral levels, and liver inflammation following treatment with long-term pegylated interferon.

6 Nov 2007

Your Apo E genotype plays part in likelihood of Alzheimer's and heart disease

We all carry the Apo E gene. It plays a key role in the development of Alzheimer's Disease and heart disease, along with a host of chronic ailments.

6 Nov 2007

Synthetic version of chlorotoxin shows promise in treatment of brain tumors

A drug developed and tested at UAB (University of Alabama at Birmingham) targeted at malignant brain tumors known as glioma has shown promising results in a Phase 1 trial, according to results presented at the American Society for Therapeutic Radiology and Oncology annual meeting.

6 Nov 2007

Fenofibrate intervention and event lowering in diabetes

Fenofibrate is the first and only widely available lipid modifying agent to demonstrate significant protection to the eye of patients with type 2 diabetes, reducing the need for laser therapy in a wide spectrum of patients which should decrease the risk of progressive loss of vision.

6 Nov 2007